Michael R. Robinson - Kensington MD, US Karl G. Csaky - Kensington MD, US Robert B. Nussenblatt - Bethesda MD, US Janine A. Smith - Potomac MD, US Peng Yuan - Rockville MD, US Cynthia Sung - Silver Spring MD, US Matthew P. Fronheiser - Durham NC, US Hyuncheol Kim - North Bethesda MD, US
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
Ocular implant devices () for the delivery of a therapeutic agent to an eye () in a controlled and sustained manner. Dual mode and single mode drug delivery devices () are illustrated and described. Implants () suitable for subconjunctival placement are described. Implants () suitable for intravitreal placement also are described. The invention also includes fabrication and implementation techniques associated with the unique ocular implant devices () that are presented herein.
Thomas R. Lehnert - Herndon VA, US Jeffrey C. Boushell - Chantilly VA, US Peng Yuan - Leesburg VA, US
Assignee:
Verizon Patent and Licensing Inc. - Basking Ridge NJ
International Classification:
G06K 9/00 G06K 9/62
US Classification:
382116, 382115, 382118, 382209
Abstract:
A system and method for identifying an unknown individual from a plurality of enrolled individuals is provided. In an embodiment, the method comprises comparing at least two parameters of the unknown individual to at least two enrolled parameters of the enrolled individuals. The method then determines a score correlating to the closeness of the comparison and then stores the score.
Ocular Therapeutic Agent Delivery Devices And Methods For Making And Using Such Devices
Michael Robinson - Kensington MD, US Karl Csaky - Kensington MD, US Peng Yuan - Rockville MD, US Cynthia Sung - Silver Spring MD, US Robert Nussenblatt - Bethesda MD, US Janine Smith - Potomac MD, US
International Classification:
A61F002/00
US Classification:
424/427000
Abstract:
Ocular implant devices for the delivery of a therapeutic agent to an eye in a controlled and sustained manner. Dual mode and single mode drug delivery devices are illustrated and described. Implants suitable for subconjunctival placement are described. Implants suitable for intravitreal placement also are described. The invention also includes fabrication and implementation techniques associated with the unique ocular implant devices that are presented herein.
Ocular Therapeutic Agent Delivery Devices And Methods For Making And Using Such Devices
Michael Robinson - Irvine CA, US Karl Csaky - Kensington MD, US Robert Nussenblatt - Bethesda MD, US Janine Smith - Potomac MD, US Peng Yuan - Rockville MD, US Cynthia Sung - Silver Spring MD, US Matthew Fronheiser - Durham NC, US Hyuncheol Kim - North Bethesda MD, US
Assignee:
Govemment of the U.S.A, represented by the Secretary, Department. of Health and Human - Rockville MD
International Classification:
A61F 2/02
US Classification:
424427000
Abstract:
Ocular implant devices () for the delivery of a therapeutic agent to an eye () in a controlled and sustained manner. Dual mode and single mode drug delivery devices () are illustrated and described. Implants () suitable for subconjunctival placement are described. Implants () suitable for intravitreal placement also are described. The invention also includes fabrication and implementation techniques associated with the unique ocular implant devices () that are presented herein.
Steroid Formulation And Methods Of Treatment Using Same
Michael Robinson - Kensington MD, US George Grimes - Rockville MD, US Luisa Gravlin - Derwood MD, US Gopal Potti - Gaithersburg MD, US Peng Yuan - Rockville MD, US Karl Csaky - Kensington MD, US
Assignee:
Government of the US, as represented by the Secretary, Department of Health and Human Services - Rockville MD
The invention provides steroid-containing pharmaceutical compositions which are free of classical preservatives and preferably comprise a steroid that is sparingly soluble or substantially insoluble in water, particulate steroid having an average particle size of from about 2.2 to about 10 microns. The pharmaceutical compositions can be used to treat medical conditions, including ophthalmological and back pain conditions.
Ocular Therapeutic Agent Delivery Devices And Methdos For Making And Using Such Devices
Michael R. Robinson - Kensington MD, US Karl G. Csaky - Kensington MD, US Robert B. Nussenblatt - Bethesda MD, US Janine A. Smith - Potomac MD, US Peng Yuan - Rockville MD, US Cynthia Sung - Silver Spring MD, US Matthew P. Fronheiser - Washington DC, US Hyuncheol Kim - Greenbelt MD, US
Assignee:
Department of Health - Rockville MD
International Classification:
A61K 9/00 B05D 3/00 A61K 38/13 A61P 27/02
US Classification:
424423, 424427, 427 214, 514 205
Abstract:
Ocular implant devices () for the delivery of a therapeutic agent to an eye () in a controlled and sustained manner. Dual mode and single mode drug delivery devices () are illustrated and described. Implants () suitable for subconjunctival placement are described. Implants () suitable for intravitreal placement also are described. The invention also includes fabrication and implementation techniques associated with the unique ocular implant devices () that are presented herein.
Thomas R. Lehnert - Herndon VA, US Jeffrey C. Boushell - Chantilly VA, US Peng Yuan - Leesburg VA, US
International Classification:
G05B 19/00
US Classification:
340 582
Abstract:
A system and method for identifying an unknown individual from a plurality of enrolled individuals is provided. In an embodiment, the method comprises comparing at least two parameters of the unknown individual to at least two enrolled parameters of the enrolled individuals. The method then determines a score correlating to the closeness of the comparison and then stores the score.
Ocular Therapeutic Agent Delivery Devices And Methods For Making And Using Such Devices
- Rockville MD, US Karl G. Csaky - Kensington MD, US Robert B. Nussenblatt - Bethesda MD, US Janine A. Smith - Potomac MD, US Peng Yuan - Rockville MD, US Cynthia Sung - Silver Spring MD, US Matthew P. Fronheiser - Washington DC, US Hyuncheol Kim - North Bethesda MD, US
Ocular implant devices () for the delivery of a therapeutic agent to an eye () in a controlled and sustained manner. Dual mode and single mode drug delivery devices () are illustrated and described. Implants () suitable for subconjunctival placement are described. Implants () suitable for intravitreal placement also are described. The invention also includes fabrication and implementation techniques associated with the unique ocular implant devices () that are presented herein.